Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS
· Delayed Price · Currency is USD
0.0020
-0.0028 (-58.33%)
Mar 9, 2026, 1:09 PM EST
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $2.61 million as of March 9, 2026. Its market cap has increased by 860.00% in one year.
Market Cap
2.61M
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 2.61M, a decrease of -97.68%. That is a compound annual growth rate of -20.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearside Biomedical | 2.62M |
| Enzolytics | 2.42M |
| ProtoKinetix | 2.39M |
| VitaSpring Biomedical | 2.30M |
| LakeShore Biopharma | 2.27M |
| Galera Therapeutics | 3.02M |
| Vaccinex | 2.13M |
| ZyVersa Therapeutics | 2.10M |